1. Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010;20(7):755-761. doi:10.1089/thy.2010.1644
2. Türkiye Endokrinoloji ve Metabolizma Derneği. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu 2023. Published 2023. Accessed October 2025. Available from: https://file.temd.org.tr/Uploads/publications/guides/documents/202305120904-2023tbl_kilavuz.pdf
3. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10): 1081-1125. doi:10.1089/thy.2011.0087
4. Takasu N, Matsushita M. Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive Graves’ patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res. 2012;2012:182176. doi:10.1155/2012/182176.
5. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves’ disease during pregnancy: optimal regimen for fetal thyroid status. N Engl J Med. 1986;315(1):24-28. doi:10.1056/NEJM 198607033150104
6. Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211-217. doi:10. 1016/S0002-9378(03)00944-X
7. Wong M, Inder WJ. Alternating hyperthyroidism and hypothyroidism in Graves’ disease. Clin Case Rep. 2018;6(9):1684-1688. doi:10.1002/ccr3. 1700
8. Ahmad E, Hafeez K, Arshad MF, Isuga J, Vrettos A. Hypothyroidism conversion to hyperthyroidism: it’s never too late. Endocrinol Diabetes Metab Case Rep. 2018;2018:18-0047. doi:10.1530/EDM-18-0047
9. McDermott MT, Ridgway EC. Hyperthyroidism following hypothyroidism. Am J Med Sci. 1986;291(3):194-198. doi:10.1097/00000 441-198603000-00006
10. Furqan S, Haque NU, Islam N. Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes. 2014;7:489. doi:10.1186/1756-0500-7-489
11. Takasu N, Yamashiro K, Ochi Y, et al. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid-stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves’ patients with hyperthyroidism. Horm Metab Res. 2001;33(4):232-237. doi:10. 1055/s-2001-14942
12. Aranyosi JK, Deli T, Erdei A, et al. Unusual onset of thyroid-associated orbitopathy during pregnancy: case report and review of literature. BMC Endocr Disord. 2020;20:183. doi:10.1186/s12902-020-00663-9
13. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-2565. doi:10.1210/jc.2011-2803
14. Van Dijke CP, Heydendael RJ, De Kleine MJ. Methimazole, carbimazole, and congenital skin defects. Ann Intern Med. 1987;106(1):60-61. doi:10. 7326/0003-4819-106-1-60
</ol>
<p>